To evaluate whether NLRP3 is an important pathogenic factor in HD, R6/2 mice (7 weeks of age, n = 16–20 per group) were treated daily with MCC950 (10 mg/kg of body weight) or water via oral administration for 5 weeks from the age of 7 weeks. This evidence concerns the gene NLRP3 and Huntington disease.